561 related articles for article (PubMed ID: 32902739)
1. Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure.
Hanna A; Frangogiannis NG
Cardiovasc Drugs Ther; 2020 Dec; 34(6):849-863. PubMed ID: 32902739
[TBL] [Abstract][Full Text] [Related]
2. Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?
Martin ML; Blaxall BC
J Cardiovasc Transl Res; 2012 Dec; 5(6):768-82. PubMed ID: 23015462
[TBL] [Abstract][Full Text] [Related]
3. The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.
Frangogiannis NG
Circ Res; 2019 Jun; 125(1):117-146. PubMed ID: 31219741
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca
Suetomi T; Willeford A; Brand CS; Cho Y; Ross RS; Miyamoto S; Brown JH
Circulation; 2018 Nov; 138(22):2530-2544. PubMed ID: 30571348
[TBL] [Abstract][Full Text] [Related]
5. Oltipraz attenuates the progression of heart failure in rats through inhibiting oxidative stress and inflammatory response.
Tang Y; Guo M; Ma XY; Sun WP; Hao MH; Zhu HY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8918-8923. PubMed ID: 30575935
[TBL] [Abstract][Full Text] [Related]
6. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
7. Cardiac fibrosis.
Frangogiannis NG
Cardiovasc Res; 2021 May; 117(6):1450-1488. PubMed ID: 33135058
[TBL] [Abstract][Full Text] [Related]
8. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
[TBL] [Abstract][Full Text] [Related]
9. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
Frangogiannis NG
Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
[TBL] [Abstract][Full Text] [Related]
10. Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure.
Khaper N; Bryan S; Dhingra S; Singal R; Bajaj A; Pathak CM; Singal PK
Antioxid Redox Signal; 2010 Oct; 13(7):1033-49. PubMed ID: 20380580
[TBL] [Abstract][Full Text] [Related]
11. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
12. Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF.
Deng Y; Xie M; Li Q; Xu X; Ou W; Zhang Y; Xiao H; Yu H; Zheng Y; Liang Y; Jiang C; Chen G; Du D; Zheng W; Wang S; Gong M; Chen Y; Tian R; Li T
Circ Res; 2021 Jan; 128(2):232-245. PubMed ID: 33176578
[TBL] [Abstract][Full Text] [Related]
13. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.
Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Li L; Higuchi M; Minatoguchi S; Fujiwara T; Fujiwara H
Cardiovasc Res; 2006 Sep; 71(4):684-94. PubMed ID: 16828072
[TBL] [Abstract][Full Text] [Related]
14. Translational overview of cytokine inhibition in acute myocardial infarction and chronic heart failure.
Hartman MHT; Groot HE; Leach IM; Karper JC; van der Harst P
Trends Cardiovasc Med; 2018 Aug; 28(6):369-379. PubMed ID: 29519701
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective Effect of (
Guo W; Wang Z; Jue H; Dong C; Yang C
Cardiovasc Ther; 2020; 2020():8584763. PubMed ID: 32426037
[TBL] [Abstract][Full Text] [Related]
16. Myocardial reverse remodeling: how far can we rewind?
Rodrigues PG; Leite-Moreira AF; Falcão-Pires I
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1402-22. PubMed ID: 26993225
[TBL] [Abstract][Full Text] [Related]
17. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
[TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction.
Zhang N; Feng B; Ma X; Sun K; Xu G; Zhou Y
Cardiovasc Diabetol; 2019 Aug; 18(1):107. PubMed ID: 31429767
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory activities of hepatocyte growth factor in post-ischemic heart failure.
Rong SL; Wang XL; Wang YC; Wu H; Zhou XD; Wang ZK; Wang YC; Xue CS; Li B; Gao DL
Acta Pharmacol Sin; 2018 Oct; 39(10):1613-1621. PubMed ID: 29795355
[TBL] [Abstract][Full Text] [Related]
20. [Molecular and cellular mechanisms of myocardial remodeling in heart failure].
Kremneva LV; Abaturova OV
Klin Med (Mosk); 2003; 81(2):4-7. PubMed ID: 12685226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
